Darvish
Alireza Darvish, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20090094182 | AUTOMATED METHODS AND SYSTEMS FOR THE DETECTION AND IDENTIFICATION OF MONEY SERVICE BUSINESS TRANSACTIONS - The present disclosure provides an automated method for the detection and identification of money service business transactions, including: performing a preprocessing operation, wherein the preprocessing operation includes filtering a dataset; performing a feature extraction operation, wherein the feature extraction operation includes extracting predetermined features from a transaction signal; performing a statistical analysis operation for the testing of significance of extracted features and dimension reduction; and performing one or more of a nonlinear classification operation and a linear classification operation, wherein the nonlinear or linear classification operation includes classifying data that appears to be related to a money service business transaction. | 04-09-2009 |
20090265218 | Method and system for media initialization via data sharing - A method, apparatus, and computer-readable medium estimate media performance on advertising space inventory. The method selects at least one media cell that shares one or more common attributes with a target media cell. The method subsequently estimates mean revenue per impression (RPI) of the selected media cell, and then defines an initial estimate of a RPI of the target media cell based on the estimated RPI of the selected cell. The method computes the RPI of the target media cell by combining the initial RPI estimate for the target media cell with performance data associated with the target media cell. | 10-22-2009 |
20130073380 | METHOD AND SYSTEM FOR MEDIA INITIALIZATION VIA DATA SHARING - A method, apparatus, and computer-readable medium estimate media performance on advertising space inventory. The method selects at least one media cell that shares one or more common attributes with a target media cell. The method subsequently estimates mean revenue per impression (RPI) of the selected media cell, and then defines an initial estimate of a RPI of the target media cell based on the estimated RPI of the selected cell. The method computes the RPI of the target media cell by combining the initial RPI estimate for the target media cell with performance data associated with the target media cell. | 03-21-2013 |
20140074597 | METHOD AND SYSTEM FOR MEDIA INITIALIZATION VIA DATA SHARING - A method, apparatus, and computer-readable medium estimate media performance on advertising space inventory. The method selects at least one media cell that shares one or more common attributes with a target media cell. The method subsequently estimates mean revenue per impression (RPI) of the selected media cell, and then defines an initial estimate of a RPI of the target media cell based on the estimated RPI of the selected cell. The method computes the RPI of the target media cell by combining the initial RPI estimate for the target media cell with performance data associated with the target media cell. | 03-13-2014 |
Daniel Darvish, Sherman Oaks, CA US
Patent application number | Description | Published |
---|---|---|
20130030040 | METHODS AND COMPOSITIONS FOR INCREASING SIALIC ACID PRODUCTION AND TREATING SIALIC RELATED DISEASE CONDITIONS - Disclosed herein are methods of expressing UDP-GlcNAc 2-Epimerase/ManNAc Kinase enzyme (GNE) peptide in a cell of a subject comprising: delivering into the cell of the subject an isolated nucleic acid expression construct that comprises a promoter operatively linked to a nucleic acid sequence encoding a GNE peptide or a therapeutically active fragment thereof, wherein the GNE peptide has the amino acid sequence of SEQ ID NO:3, wherein upon the delivering into the cell of the subject, the nucleic acid expression construct initiates expression of the GNE peptide or a therapeutically active fragment thereof. Also disclosed are methods of producing a GNE peptide in a cell comprising infecting the cell with an isolated nucleic acid construct that comprises a promoter operatively linked to a nucleic acid sequence encoding a GNE peptide or a therapeutically active fragment thereof, wherein the GNE peptide has the amino acid sequence of SEQ ID NO:3. | 01-31-2013 |
20140275230 | METHODS AND COMPOSITIONS FOR INCREASING SIALIC ACID PRODUCTION AND TREATING SIALIC RELATED DISEASE CONDITIONS - Disclosed herein are methods of expressing UDP-GlcNAc 2-Epimerase/ManNAc Kinase enzyme (GNE) peptide in a cell of a subject comprising: delivering into the cell of the subject an isolated nucleic acid expression construct that comprises a promoter operatively linked to a nucleic acid sequence encoding a GNE peptide or a therapeutically active fragment thereof, wherein the GNE peptide has the amino acid sequence of SEQ ID NO:3, wherein upon the delivering into the cell of the subject, the nucleic acid expression construct initiates expression of the GNE peptide or a therapeutically active fragment thereof. Also disclosed are methods of producing a GNE peptide in a cell comprising infecting the cell with an isolated nucleic acid construct that comprises a promoter operatively linked to a nucleic acid sequence encoding a GNE peptide or a therapeutically active fragment thereof, wherein the GNE peptide has the amino acid sequence of SEQ ID NO:3. | 09-18-2014 |
Daniel K. Darvish, Reseda, CA US
Patent application number | Description | Published |
---|---|---|
20120276560 | BIOMARKERS FOR ASSESSING SIALIC ACID DEFICIENCIES - The present invention relates to methods of diagnosing, monitoring and assessing conditions of sialic acid deficiency such as Hereditary Inclusion Body Myopathy (HIBM) and to methods of predicting/determining responsiveness to treatment. | 11-01-2012 |
Daniel Kohan Darvish, Sherman Oaks, CA US
Patent application number | Description | Published |
---|---|---|
20090298112 | MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY - Disclosed herein are methods of treating HIBM in a subject comprising identifying subject in need thereof, and administering to the subject a compound, or a pharmaceutically acceptable salt, ester, amide, glycol, peptidyl, or prodrug thereof, wherein the compound is a compound that is biosynthesized in a wild type individual along a biochemical pathway between glucose and sialic acid, inclusive. Also disclosed herein are vectors comprising a nucleic acid sequence that encodes a polypeptide having at least 80% sequence identity to the sequence set forth in SEQ ID NO:2, recombinant cells comprising these vectors, and recombinant animals comprising the cells. In addition, methods of identifying a compound having therapeutic effect for HIBM are disclosed. | 12-03-2009 |
Davis S. Darvish, Santa Monica, CA US
Patent application number | Description | Published |
---|---|---|
20130298985 | MICROELECTRONIC STRUCTURES INCLUDING CUPROUS OXIDE SEMICONDUCTORS AND HAVING IMPROVED P-N HETEROJUNCTIONS - The present invention provides strategies for making higher quality p-n heterojunctions that incorporate cuprous oxide and another material suitable for forming the heterojunction. When incorporated into microelectronic devices, these improved heterojunctions would be expected to provide improved microelectronic properties such as improved defect density, in particular lower interfacial defect density at the p-n heterojunction, leading to improved microelectronic devices such as solar cell devices with improved open circuit voltage, fill factor, efficiency, current density, and the like. | 11-14-2013 |
Diana Darvish, Saint-Petersburg RU
Patent application number | Description | Published |
---|---|---|
20140263158 | Container Having A Use Indicator - A product includes a container, and an indicator that is carried inside the container and that exhibits a first visible characteristic, and a second, different visible characteristic when exposed to air. | 09-18-2014 |
Jenna Darvish, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20110247910 | Luggage with Deployable Undercarriage - A luggage with a deployable, wheeled undercarriage and movable handles. The undercarriage has telescoping support members that can be deployed or opened to carry additional baggage and closed when not required. Wheels on the support members allow the luggage to be moved along the floor without having to tilt the luggage. This increases the stability and the amount of baggage that can be added. The handles in the deployed configuration extend behind the luggage to facilitate pushing the luggage. Deployment of the undercarriage can be manual or automatic with actuation of a deployment member, such as the handle itself. | 10-13-2011 |
Nissim Darvish, Zrufa IL
Patent application number | Description | Published |
---|---|---|
20110029000 | IN VIVO SUTURE ASSEMBLIES - Disclosed is a suturing assembly for suturing in vivo tissue. The suturing assembly comprises a first suture thread positioned along a first surface of an in vivo tissue having a first surface and a second surface and at least one suture needle configured to pass through in vivo tissue. The suturing assembly additionally comprises a suture catch located on at least one side of the at least one suture needle, the suture catch configured to releasably catch the suture and draw the suture through the in vivo tissue during a first passage through the in vivo tissue such that the suture is formed into a first loop on a surface of the in vivo tissue. | 02-03-2011 |
Nissim Darvish, Tzerufa IL
Patent application number | Description | Published |
---|---|---|
20110112625 | VARYING DIAMETER VASCULAR IMPLANT AND BALLOON - A method for deploying an expandable implant in a body passage of varying diameter includes selecting a balloon having a radial dimension that varies, when the balloon is inflated, in accordance with the varying diameter of the body passage. The balloon is inserted, in a deflated state, into the body passage, with the expandable implant fitted radially around the balloon. The balloon is inflated so as to cause the implant to open, responsively to the varying radial dimension of the balloon, into an expanded shape that approximately matches the varying diameter of the body passage, thus anchoring the implant in the body passage. | 05-12-2011 |
20130317593 | VARYING DIAMETER VASCULAR IMPLANT AND BALLOON - A method for deploying an expandable implant in a body passage of varying diameter includes selecting a balloon having a radial dimension that varies, when the balloon is inflated, in accordance with the varying diameter of the body passage. The balloon is inserted, in a deflated state, into the body passage, with the expandable implant fitted radially around the balloon. The balloon is inflated so as to cause the implant to open, responsively to the varying radial dimension of the balloon, into an expanded shape that approximately matches the varying diameter of the body passage, thus anchoring the implant in the body passage. | 11-28-2013 |
20140067041 | METHODS FOR TREATING ABNORMAL GROWTHS IN THE BODY USING A FLOW REDUCING IMPLANT - A flow reducing implant for reducing blood flow in a blood vessel having a cross sectional dimension, the flow reducing implant comprising a hollow element adapted for placement in the blood vessel defining a flow passage therethrough, said flow passage comprising at least two sections, one with a larger diameter and one with a smaller diameter, wherein said smaller diameter is smaller than a cross section of the blood vessel. A plurality of tabs anchor, generally parallel to the blood vessel wall, are provided in some embodiments of the invention. | 03-06-2014 |
20150088239 | METHODS FOR TREATING ABNORMAL GROWTHS IN THE BODY USING A FLOW REDUCING IMPLANT - A flow reducing implant for reducing blood flow in a blood vessel having a cross sectional dimension, the flow reducing implant comprising a hollow element adapted for placement in the blood vessel defining a flow passage therethrough, said flow passage comprising at least two sections, one with a larger diameter and one with a smaller diameter, wherein said smaller diameter is smaller than a cross section of the blood vessel. A plurality of tabs anchor, generally parallel to the blood vessel wall, are provided in some embodiments of the invention. | 03-26-2015 |
Nissim Darvish, Hof Hacarmel IL
Patent application number | Description | Published |
---|---|---|
20090312597 | Methods and devices for limiting gastric expansion - Disclosed are methods and devices for limiting expansion in at least one portion of gastric tissue. | 12-17-2009 |
20140236250 | ELECTRICAL MUSCLE CONTROLLER - A method of modifying the force of contraction of at least a portion of a heart chamber, including providing a subject having a heart, comprising at least a portion having an activation, and applying a non-excitatory electric field having a given duration, at a delay after the activation, to the portion, which causes the force of contraction to be increased by a least 5%. | 08-21-2014 |
20140330333 | METHODS AND DEVICES FOR MODIFYING VASCULAR PARAMETERS - A method of promoting the healing of a lesion in a smooth muscle ( | 11-06-2014 |
Nissim Darvish, Moshav Tzrufa IL
Patent application number | Description | Published |
---|---|---|
20130096639 | ELECTRICAL MUSCLE CONTROLLER - A method of modifying the force of contraction of at least a portion of a heart chamber, including providing a subject having a heart, comprising at least a portion having an activation, and applying a non-excitatory electric field having a given duration, at a delay after the activation, to the portion, which causes the force of contraction to be increased by a least 5%. | 04-18-2013 |
Nissim Darvish, Tzrufa IL
Patent application number | Description | Published |
---|---|---|
20100114299 | FLOW REDUCING IMPLANT - A flow reducing implant for reducing blood flow in a blood vessel having a cross sectional dimension, the flow reducing implant comprising a hollow element adapted for placement in the blood vessel defining a flow passage therethrough, said flow passage comprising at least two sections, one with a larger diameter and one with a smaller diameter, wherein said smaller diameter is smaller than a cross section of the blood vessel. A plurality of tabs anchor, generally parallel to the blood vessel wall, are provided in some embodiments of the invention. | 05-06-2010 |
Raphael Darvish, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20110247910 | Luggage with Deployable Undercarriage - A luggage with a deployable, wheeled undercarriage and movable handles. The undercarriage has telescoping support members that can be deployed or opened to carry additional baggage and closed when not required. Wheels on the support members allow the luggage to be moved along the floor without having to tilt the luggage. This increases the stability and the amount of baggage that can be added. The handles in the deployed configuration extend behind the luggage to facilitate pushing the luggage. Deployment of the undercarriage can be manual or automatic with actuation of a deployment member, such as the handle itself. | 10-13-2011 |
20130079850 | EM Radiation eye protection systems and methods - Electromagnetic (EM) radiation eye protection systems ( | 03-28-2013 |